BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21572448)

  • 1. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH; Kim JJ
    Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism.
    Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M
    Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
    Borst SE; Yarrow JF
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
    Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
    Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.
    Vartolomei MD; Kimura S; Vartolomei L; Shariat SF
    Eur Urol Focus; 2020 Jan; 6(1):170-177. PubMed ID: 30017901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
    Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
    Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in testosterone therapy for men.
    Corona G; Rastrelli G; Forti G; Maggi M
    J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
    Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
    J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
    Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
    Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone deficiency in older men: a problem worth treating.
    McHenry Martin C
    Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
    Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy.
    Barbonetti A; D'Andrea S; Francavilla S
    Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations.
    Giagulli VA; Triggiani V; Corona G; Carbone D; Licchelli B; Tafaro E; Resta F; Sabbà C; Maggi M; Guastamacchia E
    Curr Pharm Des; 2011; 17(15):1500-11. PubMed ID: 21521164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.